https://www.selleckchem.com/pr....oducts/tak-243-mln24
75; 95% CI, 0.67-0.83, respectively) and PCa mortality (HR, 0.80; 95% CI 0.69, 0.92) and 0.64; 95% CI, d 0.51-0.81, respectively. The effects were more pronounced in post-diagnostic users combination use of metformin/statins was associated with a 32% reduction in all-cause mortality (95% CI, 0.57-0.8, and 54% reduction in PCa mortality (95% CI, 0.30-0.69). No significant association of metformin alone was observed with either all-cause mortality or PCa mortality. CONCLUSIONS Statin use alone or in combination with metformin was